Effects of Pridopidine on Functional Capacity in Early-Stage Participants from the PRIDE-HD Study

BACKGROUND: No pharmacological treatment has been demonstrated to provide a functional benefit for persons with Huntington’s disease (HD). Pridopidine is a sigma-1-receptor agonist shown to have beneficial effects in preclinical models of HD. OBJECTIVE: To further explore the effect of pridopidine o...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Huntingtons Dis
Hlavní autoři: McGarry, Andrew, Leinonen, Mika, Kieburtz, Karl, Geva, Michal, Olanow, C. Warren, Hayden, Michael
Médium: Artigo
Jazyk:Inglês
Vydáno: IOS Press 2020
Témata:
Research Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7836066/
https://ncbi.nlm.nih.gov/pubmed/33164941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JHD-200440
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky